...a single antigen -- CD19. Patients can relapse if CD19-negative tumor cells evade treatment, Patrick Dougherty...
...MILs are naturally polyantigen specific, they recognize more than one antigen on the cell surface,” Dougherty...

...Dougherty to SVP of strategy, planning and operations. LaRochelle was CBO of PsiOxus Therapeutics Ltd.; Dougherty...

...of 16 million shares at $4 in an IPO underwritten by MDB Capital Group and Dougherty...

...of 16 million shares at $4 in an IPO underwritten by MDB Capital Group and Dougherty...

...Merrimack Pharmaceuticals Inc. (NASDAQ:MACK). Stapled peptide therapeutics company Aileron Therapeutics Inc. (Cambridge, Mass.) named Donald Dougherty...

...1,500 Price: $10,000 (unit) Shares after offering: 11.9 million Underwriters: Ladenburg Thalmann; Chardan Capital Markets; Dougherty...

...Up to $20 million Units: 2,000 Price prior: $1.31 Underwriters: Ladenburg Thalmann; Chardan Capital Markets; Dougherty...
...amended its offering and proposed to sell 2,000 units. The company also added Chardan and Dougherty...

...tracks Joseph Dougherty, founder and managing director of Seaview Securities, passed away late last month. Dougherty's...

...3.3 million Price: $14 Shares after offering: 9.3 million Underwriters: Aegis Capital; Feltl; Cantor Fitzgerald; Dougherty...

...total raised includes 428,700 shares sold in the overallotment. Aegis Capital; Feltl; Cantor Fitzgerald; and Dougherty...